Summary
Brenntag AG shares declined on Tuesday after Deutsche Bank moved the stock from a "buy" to a "hold" recommendation and reduced its price target to €57 from €67. The bank flagged the possibility that an easing of conflict-related pressures in the Middle East could eliminate several temporary advantages distributors had enjoyed, particularly for firms with strong exposure to oil-linked commodity chemicals.
Market reaction
Shares of Brenntag fell following the note from Deutsche Bank. Market data cited in the communication showed Brenntag down around the mid-single-digit percentage on the day, with peers also registering modest declines - IMCD about -1.1% and Azelis about -1.55%.
Analyst reasoning
Deutsche Bank analyst Tristan Lamotte wrote that chemical distributors were expected to benefit from the conflict in the Middle East because higher chemical prices and supply disruptions typically support distributor margins and volumes. Brenntag was identified as the biggest beneficiary among its peer group, which the note listed as including IMCD and Azelis, owing to Brenntag's higher exposure to oil-linked commodity chemicals.
Lamotte cautioned that these gains may not be durable if tensions ease. As he put it, "However, with a provisional path towards de_escalation, the risk is normalisation," and he added that Brenntag was "most exposed to a reversal in pricing and disruption-related tailwinds."
Peer comparison and longer-term outlook
Deutsche Bank said IMCD and Azelis are not immune to weakening prices, but argued that their more measured pricing gains during the conflict should make them less susceptible to downside volatility as conditions normalise. Looking further ahead, the bank continued to view both Azelis and IMCD as undervalued. It pointed to the specialty distributors' track record, noting average organic revenue growth of approximately 4.6% since 2014 - a rate that outgrew producers by 2.7 percentage points annually - along with value-accretive mergers and acquisitions.
Implications
The note underscores how sector performance has been influenced by geopolitical developments and the sensitivity of distributor revenues and margins to commodity-linked price swings. Investors in chemical distributors should consider both the temporary benefits of conflict-driven dislocations and the potential for normalisation if tensions subside.